Immune-Cell-Derived Exosomes for Cancer Therapy

Area of Science:

• Immunology
• Nanotechnology
• Oncology

Background:

• Exosomes are extracellular vesicles crucial for cell-cell communication.
• Immune-cell-derived exosomes possess immunomodulatory properties and therapeutic potential in cancer.
• They serve as effective drug delivery platforms due to biocompatibility and high loading capacity.

Purpose of the Study:

• To comprehensively review the biological and therapeutic characteristics of immune-cell-derived exosomes.
• To systematically summarize their antitumor mechanisms.
• To discuss their applications as nanocarriers for antitumor agents and existing challenges.

Main Methods:

• Literature review of studies on immune-cell-derived exosomes in cancer therapy.
• Analysis of exosome surface antigens for immunological activation.
• Evaluation of exosomes as drug delivery systems for chemotherapeutics, genes, and proteins.

Main Results:

• Immune-cell-derived exosomes exhibit potent antitumor effects through antigen presentation and immune activation.
• Macrophages, dendritic cells, T cells, B cells, and NK cells secrete exosomes with distinct antitumor mechanisms.
• Exosomes demonstrate significant potential as nanocarriers for targeted delivery of anticancer agents.

Conclusions:

• Immune-cell-derived exosomes are versatile therapeutic agents and drug delivery platforms for cancer treatment.
• Further research is needed to overcome challenges and fully realize their antitumor potential.
• These exosomes offer a promising avenue for developing novel cancer immunotherapies.